FINWIRES · TerminalLIVE
FINWIRES

Wedbush Raises Intellia Therapeutics Price Target to $17 From $12, Maintains Neutral Rating

By

Price: $15.51, Change: $-1.33, Percent Change: -7.90%

Related Articles

Wedbush Raises Intellia Therapeutics Price Target to $17 From $12, Maintains Neutral Rating | FINWIRES